Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis
Year: 2014
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm500305p
Authors: Yan Lou, Xiaochun Han, Andreas Kuglstatter, Rama K. Kondru, Zachary K. Sweeney, Michael Soth, Joel McIntosh, Renee Litman, Judy Suh, Buelent Kocer, Dana Davis, Jaehyeon Park, Sandra Frauchiger, Nolan Dewdney, Hasim Zecic, Joshua P. Taygerly, Keshab Sarma, Junbae Hong, Ronald J. Hill, Tobias Gabriel, David M. Goldstein, Timothy D. Owens
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2131531959
